Feb. 22 (Bloomberg) — John Sullivan, director of equity research at Leerink Swann & Co., talks with Bloomberg’s Lori Rothman about his recommendation of Pfizer Inc. and Merck & Co

Feb. 5 (Bloomberg) — Stanley Bergman, chief executive officer of Henry Schein Inc., talks with Bloomberg’s Pimm Fox about the performance of the company’s business units, including its animal-health joint venture, and the outlook for Henry Schein’s Hong Kong-based dental business. (Source: Bloomberg)